1887

Abstract

SUMMARY

Passive transfer of monoclonal antibodies specific for herpes simplex virus type 1 (HSV-1) glycoproteins gC or gD resulted in the generation of highly potent HSV-specific and H-2-restricted primary cytotoxic T-lymphocytes (CTL) in the lymph nodes of recipients provided they were injected at 12 h post-infection. When the same antibody was injected at 3 h before HSV infection, the recipients failed to generate primary anti-HSV CTL. Rather, lymph node cells from such donors proved unsuitable for the initiation of a secondary anti-HSV CTL response by restimulation.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-64-9-2033
1983-09-01
2024-11-14
Loading full text...

Full text loading...

/deliver/fulltext/jgv/64/9/JV0640092033.html?itemId=/content/journal/jgv/10.1099/0022-1317-64-9-2033&mimeType=html&fmt=ahah

References

  1. Balachandran N., Bacchetti S., Rawls W. E. 1982; Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2. Infection and Immunity 37:1132–1137
    [Google Scholar]
  2. Dix R. D., Pereira L., Baringer J. R. 1981; Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease. Infection and Immunity 34:192–199
    [Google Scholar]
  3. Greenspan N., Doherty P. C. 1981; Modification of cytotoxic T-cell response patterns by administration of hemagglutinin-specific monoclonal antibodies to mice infected with influenza A viruses. Hybridoma 1:149–159
    [Google Scholar]
  4. Howes E. L., Taylor W., Mitchison N. A., Simpson E. 1979; MHC matching shows that at least two T-cell subsets determine resistance to HSV. Nature, London 277:67–68
    [Google Scholar]
  5. Kastrukoff L. F., Long C., Koprowski H. 1981; Herpes simplex virus immune system interaction in a murine model. In The Human Herpesviruses: Interdisciplinary Perspective pp 320–325 Edited by Nahmias A. J., Dowdle W. R., Schinazi R. E. New York: Elsevier;
    [Google Scholar]
  6. Lawman M. J. P., Rouse B. T., Courtney R. J., Walker R. D. 1980; Cell-mediated immunity against herpes simplex induction of cytotoxic T lymphocytes. Infection and Immunity 27:133–139
    [Google Scholar]
  7. Nash A. A., Quartey-Papafio R., Wildy P. 1980; Cell-mediated immunity in herpes simplex virus-infected mice: functional analysis of lymph node cells during periods of acute and latent infection, with reference to cytotoxic and memory cells. Journal of General Virology 49:309–317
    [Google Scholar]
  8. Naylor P. T., Larsen H. S., Huang L., Rouse B. T. 1982; In vivo induction of anti-herpes simplex virus immune response by type 1 antigens and lipid A incorporated into liposomes. Infection and Immunity 36:1209–1216
    [Google Scholar]
  9. Norrild B., Shore S. L., Nahmias A. J. 1979; Herpes simplex virus glycoproteins: participation of individual herpes simplex virus type 1 glycoprotein antigens in immunocytolysis and their correlation with previously identified glycopolypeptides. Journal of Virology 32:741–748
    [Google Scholar]
  10. Norrild B., Shore S. L., Cromeans T. L., Nahmias A. I. 1980; Participation of three major glycoprotein antigens of herpes simplex virus type 1 early in infectious cycle as determined by antibody-dependent cell mediated cytotoxicity. Infection and Immunity 28:38–44
    [Google Scholar]
  11. Pfizenmaier K., Jung H., Starzinski-Powitz A., Röllinghoff M., Wagner H. 1977; The role of T Cells in anti-herpes simplex virus immunity. I. Induction of antigen-specific cytotoxic T lymphocytes. Journal of Immunology 119:939–944
    [Google Scholar]
  12. Rector J. T., Lausch R. N., Oakes J. E. 1982; Use of monoclonal antibodies for analysis of antibody-dependent immunity to ocular herpes simplex virus type 1 infection. Infection and Immunity 38:168–174
    [Google Scholar]
  13. Sethi K. K., Brandis H. 1977; Specifically immune mouse T-cells can destroy H-2 compatible murine target cells infected with herpes simplex virus type 1 or 2. Zeitschrift für Immunitatsforschung 150:162–173
    [Google Scholar]
  14. Sethi K. K., Brandis H. 1980; Production of neutralizing antibody to rabies and vesicular stomatitis viruses by hybrid cell lines. Cellular Immunology 49:260–265
    [Google Scholar]
  15. Sethi K. K., Brandis H. 1981; Generation of hybridoma cell lines producing monoclonal antibodies against Toxoplasma gondii or rabies virus following fusion of in vitro immunized spleen cells with myeloma cells. Annates d’lmmunologie 132C:29–41
    [Google Scholar]
  16. Sethi K. K., Wolff M. H. 1980; The nature of host-cell herpes simplex virus interaction(s) that render cells susceptible to virus-specific cytotoxic T-cells. Immunobiology 157:365–378
    [Google Scholar]
  17. Sethi K. K., Stroehmann I., Brandis H. 1980; Human T cell cultures from virus sensitized donors can mediate virus-specific and HLA-restricted cell lysis. Nature, London 286:718–720
    [Google Scholar]
  18. Shore S. L., Nahmias A. J., Starr S. E., Wood P. A., McFarlin D. E. 1974; Detection of cell-dependent cytotoxic antibody to cells infected with herpes simplex virus. Nature, London 251:350–352
    [Google Scholar]
  19. Showalter S. D., Zweig M., Hampar B. 1981; Monoclonal antibodies to herpes simplex virus type 1 proteins, including the immediate-early protein ICP 4. Infection and Immunity 34:684–692
    [Google Scholar]
  20. Sonoda S., Hitsumoto Y., Utsumi S., Takami S., Oseto M., Minamishima Y. 1981; Preparation of stable target cells for anti-herpes simplex virus cytotoxic T lymphocytes. Microbiology and Immunology 25:999–1010
    [Google Scholar]
  21. Wagner H., Röllinghoff M. 1978; T-T cell interaction during in vitro cytotoxic allograft responses. I. Soluble products from activated Ly 1+ T cells trigger autonomously antigen-primed Ly2 3+ T cells to proliferation and cytotoxic activity. Journal of Experimental Medicine 148:1523–1538
    [Google Scholar]
  22. Zisman R. B., Allison A. C. 1976; Mechanism of immunologic resistance to herpes simplex virus 1 (HSV-1) infection. Journal of Immunology 116:35–40
    [Google Scholar]
/content/journal/jgv/10.1099/0022-1317-64-9-2033
Loading
/content/journal/jgv/10.1099/0022-1317-64-9-2033
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error